with todays amrn news i dont see how any of the big pharma companies with any statin drug on the market would not be interested in buying or partnership with amrn. why not it makes the statin drug better. is this how others see it as well??
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.